The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.

Recent research presents a novel approach to managing the risks posed by Vibrio parahaemolyticus, a common yet hazardous ...

A sustainable food system for a growing global population requires a more diversified and climate-neutral protein production.

OVER half of Brits are secretly battling a ‘silent killer’ condition, according to new data – and it’s recently been linked ...

Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...